The updated 2017 WHO tumor classification divided pancreatic neuroendocrine carcinomas into G3 NETs characterized by Ki67 > 20% and a well-differentiated morphology, or G3 NECs characterized by Ki67%>20% and the absence of a low-grade component [14]. The gene discussed is MKI67; the disease is pancreatic endocrine carcinoma.